Be aware of the cognitive and metabolic risks associated with topiramate
Zhang R, Tang L, Wang Y et al (2023) dendrimer peptide (KK2DP7) delivery system with dual functions of lymph node targeting and immune adjuvants as a general strategy for cancer immunotherapy
The GLP-1RAs, particularly semaglutide, are now used on a global scale for diabetes and obesity, and emerging pharmacovigilance reports suggest that some patients may experience oral and salivary symptoms during therapy, including xerostomia, dysgeusia, oral hypoesthesia, and throat discomfort [1]
Palmitoylation and trafficking of GAD65 are impaired in a cellular model of Huntington's disease
The protocol follows a careful dose escalation schedule that begins with 0.25mg weekly during the first four weeks
Theres no direct interaction, but there are some potentially negative effects